BioNTech and Pfizer Tout Drug Trial Results

4 stories

June 1

Immuneering Corporation (IMRX) Discusses Positive Atebimetinib ASCO Data Update in First-Line Pancreatic Cancer Transcript
Seeking Alpha · Jun 1
STAT+: A turning point for pancreatic cancer patients
statnews.com · Jun 1

May 30

Apogee Therapeutics, Inc. (APGE) Discusses Positive Part B Results From Phase 2 APEX Trial of Zumilokibart in Atopic Dermatitis - Slideshow
Seeking Alpha · May 30
STAT+: BioNTech and Pfizer tout bispecifics data, and Pazdur sees silver lining at FDA
statnews.com · May 30

BioNTech and Pfizer Tout Drug Trial Results | Clustered News